This article was originally published in The Tan Sheet
International Trade Administration postpones preliminary determination on Chinese aspirin "dumping" until Dec. 21. The Commerce Department announced the bulk aspirin antidumping duty investigation in June, with a preliminary determination due by Nov. 4. ITA delayed its preliminary findings at the request of Cranbury, N.J.-based bulk aspirin manufacturer Rhodia, a Rhone-Poulenc S.A. subsidiary, which is seeking the imposition of antidumping duties on bulk aspirin imports from the People's Republic of China (1"The Tan Sheet" June 14, p. 9)
You may also be interested in...
The International Trade Commission is instituting an investigation into evidence of possible Chinese aspirin "dumping" onto the U.S. market, the commission announced in the Federal Register June 7. The investigation follows a May 28 petition from bulk aspirin manufacturer Rhodia requesting the "imposition of antidumping duties on imports of bulk aspirin from the People's Republic of China."
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning